Recent developments in membrane targeting antifungal agents to mitigate antifungal resistance

RSC Med Chem. 2023 Jun 26;14(9):1603-1628. doi: 10.1039/d3md00151b. eCollection 2023 Sep 19.ABSTRACTFungal infections cause severe and life-threatening complications especially in immunocompromised individuals. Antifungals targeting cellular machinery and cell membranes including azoles are used in clinical practice to manage topical to systemic fungal infections. However, continuous exposure to clinically used antifungal agents in managing the fungal infections results in the development of multi-drug resistance via adapting different kinds of intrinsic and extrinsic mechanisms. The unique chemical composition of fungal membranes presents attractive targets for antifungal drug discovery as it is difficult for fungal cells to modify the membrane targets for emergence of drug resistance. Here, we discussed available antifungal drugs with their detailed mechanism of action and described different antifungal resistance mechanisms. We further emphasized structure-activity relationship studies of membrane-targeting antifungal agents, and classified membrane-targeting antifungal agents on the basis of their core scaffold with detailed pharmacological properties. This review aims to pique the interest of potential researchers who could explore this interesting and intricate fungal realm.PMID:37731690 | PMC:PMC10507810 | DOI:10.1039/d3md00151b
Source: Cell Research - Category: Cytology Authors: Source Type: research